FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3147429611> ?p ?o ?g. }

• W3147429611 endingPage "2123" @default.
• W3147429611 startingPage "2123" @default.
• W3147429611 abstract "Two new ultra-high performance liquid chromatography (UHPLC) methods for analyzing 21 selected antivirals and their metabolites were optimized, including sample preparation step, LC separation conditions, and tandem mass spectrometry detection. Micro-solid phase extraction in pipette tips was used to extract antivirals from the biological material of Hanks balanced salt medium of pH 7.4 and 6.5. These media were used in experiments to evaluate the membrane transport of antiviral drugs. Challenging diversity of physicochemical properties was overcome using combined sorbent composed of C18 and ion exchange moiety, which finally allowed to cover the whole range of tested antivirals. For separation, reversed-phase (RP) chromatography and hydrophilic interaction liquid chromatography (HILIC), were optimized using extensive screening of stationary and mobile phase combinations. Optimized RP-UHPLC separation was carried out using BEH Shield RP18 stationary phase and gradient elution with 25 mmol/L formic acid in acetonitrile and in water. HILIC separation was accomplished with a Cortecs HILIC column and gradient elution with 25 mmol/L ammonium formate pH 3 and acetonitrile. Tandem mass spectrometry (MS/MS) conditions were optimized in both chromatographic modes, but obtained results revealed only a little difference in parameters of capillary voltage and cone voltage. While RP-UHPLC-MS/MS exhibited superior separation selectivity, HILIC-UHPLC-MS/MS has shown substantially higher sensitivity of two orders of magnitude for many compounds. Method validation results indicated that HILIC mode was more suitable for multianalyte methods. Despite better separation selectivity achieved in RP-UHPLC-MS/MS, the matrix effects were noticed while using both chromatographic modes leading to signal enhancement in RP and signal suppression in HILIC." @default.
• W3147429611 created "2021-04-13" @default.
• W3147429611 creator A5002827640 @default.
• W3147429611 creator A5004770003 @default.
• W3147429611 creator A5023026842 @default.
• W3147429611 creator A5024071835 @default.
• W3147429611 creator A5037800103 @default.
• W3147429611 creator A5038193861 @default.
• W3147429611 creator A5056386323 @default.
• W3147429611 creator A5059706171 @default.
• W3147429611 creator A5088591294 @default.
• W3147429611 date "2021-04-07" @default.
• W3147429611 modified "2023-10-16" @default.
• W3147429611 title "Determination of Antiviral Drugs and Their Metabolites Using Micro-Solid Phase Extraction and UHPLC-MS/MS in Reversed-Phase and Hydrophilic Interaction Chromatography Modes" @default.
• W3147429611 cites W1969581657 @default.
• W3147429611 cites W1977327813 @default.
• W3147429611 cites W1977685796 @default.
• W3147429611 cites W1983608029 @default.
• W3147429611 cites W2039693707 @default.
• W3147429611 cites W2099936859 @default.
• W3147429611 cites W2138041531 @default.
• W3147429611 cites W2165150310 @default.
• W3147429611 cites W2340843616 @default.
• W3147429611 cites W2410066853 @default.
• W3147429611 cites W2514375941 @default.
• W3147429611 cites W2583744239 @default.
• W3147429611 cites W2626997571 @default.
• W3147429611 cites W2726662689 @default.
• W3147429611 cites W2727636141 @default.
• W3147429611 cites W2772765547 @default.
• W3147429611 cites W2798103833 @default.
• W3147429611 cites W2800353572 @default.
• W3147429611 cites W2865351935 @default.
• W3147429611 cites W2894153843 @default.
• W3147429611 cites W2913680658 @default.
• W3147429611 cites W2972081667 @default.
• W3147429611 cites W2997266813 @default.
• W3147429611 cites W3000281717 @default.
• W3147429611 cites W3034401411 @default.
• W3147429611 cites W3035311794 @default.
• W3147429611 cites W3095682953 @default.
• W3147429611 cites W3126257953 @default.
• W3147429611 cites W3127262560 @default.
• W3147429611 cites W3127514794 @default.
• W3147429611 cites W3133133954 @default.
• W3147429611 cites W4253948979 @default.
• W3147429611 doi "https://doi.org/10.3390/molecules26082123" @default.
• W3147429611 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8067820" @default.
• W3147429611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33917128" @default.
• W3147429611 hasPublicationYear "2021" @default.
• W3147429611 type Work @default.
• W3147429611 sameAs 3147429611 @default.
• W3147429611 citedByCount "7" @default.
• W3147429611 countsByYear W31474296112021 @default.
• W3147429611 countsByYear W31474296112022 @default.
• W3147429611 countsByYear W31474296112023 @default.
• W3147429611 crossrefType "journal-article" @default.
• W3147429611 hasAuthorship W3147429611A5002827640 @default.
• W3147429611 hasAuthorship W3147429611A5004770003 @default.
• W3147429611 hasAuthorship W3147429611A5023026842 @default.
• W3147429611 hasAuthorship W3147429611A5024071835 @default.
• W3147429611 hasAuthorship W3147429611A5037800103 @default.
• W3147429611 hasAuthorship W3147429611A5038193861 @default.
• W3147429611 hasAuthorship W3147429611A5056386323 @default.
• W3147429611 hasAuthorship W3147429611A5059706171 @default.
• W3147429611 hasAuthorship W3147429611A5088591294 @default.
• W3147429611 hasBestOaLocation W31474296111 @default.
• W3147429611 hasConcept C116817701 @default.
• W3147429611 hasConcept C162356407 @default.
• W3147429611 hasConcept C179998833 @default.
• W3147429611 hasConcept C185592680 @default.
• W3147429611 hasConcept C2775986502 @default.
• W3147429611 hasConcept C2777379063 @default.
• W3147429611 hasConcept C2777463227 @default.
• W3147429611 hasConcept C31827203 @default.
• W3147429611 hasConcept C43617362 @default.
• W3147429611 hasConcept C4725764 @default.
• W3147429611 hasConcept C64489805 @default.
• W3147429611 hasConcept C73826308 @default.
• W3147429611 hasConcept C81426234 @default.
• W3147429611 hasConceptScore W3147429611C116817701 @default.
• W3147429611 hasConceptScore W3147429611C162356407 @default.
• W3147429611 hasConceptScore W3147429611C179998833 @default.
• W3147429611 hasConceptScore W3147429611C185592680 @default.
• W3147429611 hasConceptScore W3147429611C2775986502 @default.
• W3147429611 hasConceptScore W3147429611C2777379063 @default.
• W3147429611 hasConceptScore W3147429611C2777463227 @default.
• W3147429611 hasConceptScore W3147429611C31827203 @default.
• W3147429611 hasConceptScore W3147429611C43617362 @default.
• W3147429611 hasConceptScore W3147429611C4725764 @default.
• W3147429611 hasConceptScore W3147429611C64489805 @default.
• W3147429611 hasConceptScore W3147429611C73826308 @default.
• W3147429611 hasConceptScore W3147429611C81426234 @default.
• W3147429611 hasFunder F4320309872 @default.
• W3147429611 hasIssue "8" @default.
• W3147429611 hasLocation W31474296111 @default.
• W3147429611 hasLocation W31474296112 @default.
• W3147429611 hasOpenAccess W3147429611 @default.

• next